Article

Pfizer commits $800,000 to EyeCare America program

New York-Pfizer Ophthalmics has awarded an $800,000 grant to EyeCare America’s Glaucoma EyeCare Program, which promotes the early detection and treatment of glaucoma by raising awareness of risk factors and providing free access to glaucoma eye exams. The grant will support the program for 2 years.

New York-Pfizer Ophthalmics has awarded an $800,000 grant to EyeCare America’s Glaucoma EyeCare Program, which promotes the early detection and treatment of glaucoma by raising awareness of risk factors and providing free access to glaucoma eye exams. The grant will support the program for 2 years.

The public service program of the Foundation of the American Academy of Ophthalmology (AAO) is a nationwide effort through which 7,300 AAO members volunteer to offer glaucoma eye exams and treatment, if necessary, at no cost to eligible uninsured people. The program is designed for U.S. citizens or legal residents who have not had an eye exam in the past 12 months, are at increased risk for glaucoma, and do not receive health care through a managed-care organization or the U.S. Department of Veterans Affairs.

Pfizer Ophthalmics presented the check to EyeCare America at the AAO annual meeting in November.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times)  ASCRS 2025: Joaquin De Rojas, MD, leverages machine learning model to predict arcuate outcomes
(Image credit: Ophthalmology Times) ASCRS 2025: AnnMarie Hipsley, DPT, PhD, presents VESA for biomechanical simulation of presbyopia progression
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
© 2025 MJH Life Sciences

All rights reserved.